Gene · 1441
Papers3,351
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,351
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case Report: Blood single-cell analysis of a IVB high-grade serous ovarian cancer patient presenting a favorable prognosis. | Front Oncol | 2025 | 41367869 | PubTator, text mining | PubMed |
| Omics and artificial intelligence integration for stratifying blast crisis CML using COSMIC signatures and pan-cancer precision drug repurposing. | World J Clin Oncol | 2025 | 41355924 | PubTator, text mining | PubMed |
| Genetic characterization of pediatric B-cell acute lymphoblastic leukemia in Argentina uncovers molecular heterogeneity and novel variants. | Front Pharmacol | 2025 | 41333018 | PubTator, text mining | PubMed |
| Analysis and Interpretation of Somatic NMD-Escaping Variants in Oncogenes and Dual-Function Genes across Adult and Pediatric Cancer Cohorts. | medRxiv | 2025 | 41332868 | PubTator, text mining | PubMed |
| IFN-I-Mediated Transcriptional Reprogramming Drives Myeloid-skewed Hematopoiesis in Sickle Cell Anemia. | Res Sq | 2025 | 41282081 | PubTator, text mining | PubMed |
| Abnormal RH antigen expression in myeloid malignancies with MPL mutation, CSF3R mutation, or 1p deletion: Evidence of two distinct mechanisms. | Transfusion | 2025 | 41263452 | PubTator, text mining | PubMed |
| Dysregulated arginine metabolism is associated with pro-tumor neutrophil polarization in liver cancer. | Front Immunol | 2025 | 41208994 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and therapeutic targets for underactive bladder based on bioinformatics analysis and experimental validation. | PLoS One | 2025 | 41196851 | PubTator, text mining | PubMed |
| Colony-Stimulating Factor 3 Receptor Mutations and Variants in Hematological Malignancies. | Cancers (Basel) | 2025 | 41154433 | PubTator, text mining | PubMed |
| Non-Malignant Granulocyte and Monocyte Disorders: An Update. | Br J Biomed Sci | 2025 | 41141324 | PubTator, text mining | PubMed |
| Genetic variation in targets of granulocyte colony-stimulating factor drugs and 14 cancers risk: A Mendelian randomization study. | Medicine (Baltimore) | 2025 | 41137358 | PubTator, text mining | PubMed |
| Clinical association and potential molecular mechanisms of neonatal sepsis and necrotizing enterocolitis. | Front Mol Biosci | 2025 | 41113854 | PubTator, text mining | PubMed |
| Impact of Somatic Gene Mutations on Prognosis Prediction in De Novo AML: Unraveling Insights from a Systematic Review and Meta-Analysis. | Cancers (Basel) | 2025 | 41097716 | PubTator, text mining | PubMed |
| Single-cell RNA-seq combined with bulk RNA-seq analysis identifies necroptosis-related genes as therapeutic targets for periodontitis. | BMC Med Genomics | 2025 | 41088263 | PubTator, text mining | PubMed |
| Associations of 2923 Olink proteins with demographic, lifestyle, environmental and health characteristics in middle-aged Chinese adults. | Eur J Epidemiol | 2025 | 41071435 | PubTator, text mining | PubMed |
| [Patient with severe congenital neutropenia associated with ELANE gene mutation: c.684C>G, p.Tyr228Ter]. | Rev Alerg Mex | 2025 | 41037715 | PubTator, text mining | PubMed |
| AdaSemb: an adaptive knowledge-driven deep learning framework integrating cancer protein assemblies for predicting PI3Kα inhibitor response and resistance. | Brief Bioinform | 2025 | 41020523 | PubTator, text mining | PubMed |
| Implantable Bioresorbable Scaffold with Fucosylated Chondroitin Sulfate as a Promising Device for Delayed Stimulation of Hematopoiesis. | Mar Drugs | 2025 | 41003313 | PubTator, text mining | PubMed |
| Single-Cell transcriptomic profiles of peripheral blood immune cells reveal early monocyte and platelet activation in the transition from high-risk states to clinical sepsis. | Sci Rep | 2025 | 40998960 | PubTator, text mining | PubMed |
| Lung NR3C1+ and CXCR6high T cells distinguish immunopathogenesis of human emphysema. | Commun Biol | 2025 | 40993192 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1441/papers?page=5